|
Market Cap (1-Jul) $176,237,888 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.009 |
RAP released this announcement to the ASX on 20 September 2021, 8:30. The announcement is not marked as price sensitive, and is 2 page(s) in length and 110.38kb in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.182% short sold according to ASIC data. It was ranked the 391st most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| First patients recruited in COVID-19 clinical study in India | 20 September 2021, 8:30 |
| ResApp receives Advanced and Overseas R&D Finding | 14 September 2021, 8:30 |
| ResAppDx receives regulatory approval in Indonesia | 1 September 2021, 8:35 |
| Appendix 4G | 27 August 2021, 9:43 |
You must be logged in to post a reply.
ResApp Health 